Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Are Microarray-Derived Gene Expression Signatures Useful as a Routine Assay for Prognostic Evaluation of Acute Myeloid Leukemia Samples with Low Leukemic Blast Content ?.

Philippe Guardiola, MD, Diane Lambert, PhD, Pascale Cornillet-Lefebvre, MD, PhD, Anne Coutolleau, Laurence Baranger, MD, Franck Genevieve, MD, PhD, Isabelle Luquet, MD, PhD, Annaelle Beucher, Marc Zandecki, PhD, Norbert Ifrah, MD, Odile Blanchet, MD, PhD

Blood (2010) 116 (21): 1658.

https://doi.org/10.1182/blood.V116.21.1658.1658

Published: 2010

Journal Articles

SNP-Arrays: a Routine Cytogenetic Tool In Chronic Lymphocytic Leukemia ?.

Alban Godon, MD, Franck Genevieve, MD, Malgorzata Truchan-Graczyk, MD, Laurence Baranger, MD, Virginie Eclache, MD, Anne Coutolleau, Norbert Ifrah, MD, PhD, Marc Zandecki, MD, PhD, Philippe Guardiola, MD

Blood (2010) 116 (21): 4611.

https://doi.org/10.1182/blood.V116.21.4611.4611

Published: 2010

Journal Articles

Morphology of Bone Marrow Plasma Cells (BMPC) and Its Relationship with Interphase Cytogenetics and Prognosis in Multiple Myeloma (MM).

Xavier Leleu, Jean E. Goasguen, MD, PhD, Claire Mathiot, MD, Richard Garand, PhD, Murielle Roussel, MD, Michel Attal, MD, Philippe Moreau, MD, Jean-Luc Harousseau, MD, Thierry Facon, MD, Hervé Avet-Loiseau, MD, PhD, Marc Zandecki, PhD

Blood (2009) 114 (22): 1822.

https://doi.org/10.1182/blood.V114.22.1822.1822

Published: 2009

Journal Articles

FOXC1, a New Prognostic Marker in Adult Acute Myeloid Leukemia (AML).

Odile Blanchet, MD, PhD, Frederique Galopin, MD, Derek Stirewalt, MD, Mathilde Hunault-Berger, MD, PhD, Annaelle Beucher, Era Pogosova-Agadjanyan, Lejla Ibricevic, MD, Laurence Baranger, MD, Franck Genevieve, MD, Marc Zandecki, MD, PhD, Norbert Ifrah, MD, Jerald P. Radich, MD, Philippe Guardiola, MD

Blood (2007) 110 (11): 2387.

https://doi.org/10.1182/blood.V110.11.2387.2387

Published: 2007

Journal Articles

Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du Myélome

Blood (2007) 109 (8): 3489–3495.

https://doi.org/10.1182/blood-2006-08-040410

Published: 2007

Includes: Supplemental data

Journal Articles

Plasma Cell Proliferation Using Ki67 Antigen Expression Defines Subgroups Related to Short Survival in Multiple Myeloma Especially with Low Beta-2 Microglobulin.

Thomas Gastinne, Xavier Leleu, Anne-Sophie Moreau, Joris Andrieux, Jean-Luc Lai, Valérie Coiteux, Ibrahim Yakoub-Agha, Francis Bauters, Philippe Moreau, Jean-Luc Harousseau, Thierry Facon, Marc Zandecki

Blood (2006) 108 (11): 5031.

https://doi.org/10.1182/blood.V108.11.5031.5031

Published: 2006

Journal Articles

Predictive Diagnostic and Prognostic Value of Platelets Microparticles (PMP), but Not of Reticulated Platelets (RP) or CD36 Expression in Essential Thrombocythaemia.

Catherine Ternisien, MD-PhD, Marie-Pierre Moles, Aline Tanguy-Schmidt, Irene Dobo, Martine Gardembas, MD, Franck Geneviève, MD, Marc Zandecki, PhD, Norbert Ifrah, MD, Mathilde Hunault-Berger, MD-PhD

Blood (2004) 104 (11): 4745.

https://doi.org/10.1182/blood.V104.11.4745.4745

Published: 2004

Journal Articles

Chromosome 13 abnormalities identified by FISH analysis and serum β 2 -microglobulin produce a powerful myeloma staging system for patients receiving high-dose therapy

Thierry Facon, Hervé Avet-Loiseau, Gaëlle Guillerm, Philippe Moreau, Franck Geneviève, Marc Zandecki, Jean-Luc Laı̈, Xavier Leleu, Jean-Pierre Jouet, Francis Bauters, Jean-Luc Harousseau, Régis Bataille, Jean-Yves Mary

Blood (2001) 97 (6): 1566–1571.

https://doi.org/10.1182/blood.V97.6.1566

Published: 2001

Journal Articles

Several Cytogenetic Subclones May Be Identified Within Plasma Cells From Patients With Monoclonal Gammopathy of Undetermined Significance, Both at Diagnosis and During the Indolent Course of This Condition

Marc Zandecki, Jean-Luc Laı̈, Franck Geneviève, Franck Bernardi, Hélène Volle-Rémy, Odile Blanchet, Michel François, Alain Cosson, Francis Bauters, Thierry Facon

Blood (1997) 90 (9): 3682–3690.

https://doi.org/10.1182/blood.V90.9.3682

Published: 1997

NARROW

Are Microarray-Derived Gene Expression Signatures Useful as a Routine Assay for Prognostic Evaluation of Acute Myeloid Leukemia Samples with Low Leukemic Blast Content ?.

SNP-Arrays: a Routine Cytogenetic Tool In Chronic Lymphocytic Leukemia ?.

Morphology of Bone Marrow Plasma Cells (BMPC) and Its Relationship with Interphase Cytogenetics and Prognosis in Multiple Myeloma (MM).

FOXC1, a New Prognostic Marker in Adult Acute Myeloid Leukemia (AML).

Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du Myélome

Plasma Cell Proliferation Using Ki67 Antigen Expression Defines Subgroups Related to Short Survival in Multiple Myeloma Especially with Low Beta-2 Microglobulin.

Predictive Diagnostic and Prognostic Value of Platelets Microparticles (PMP), but Not of Reticulated Platelets (RP) or CD36 Expression in Essential Thrombocythaemia.

Chromosome 13 abnormalities identified by FISH analysis and serum β 2 -microglobulin produce a powerful myeloma staging system for patients receiving high-dose therapy

Several Cytogenetic Subclones May Be Identified Within Plasma Cells From Patients With Monoclonal Gammopathy of Undetermined Significance, Both at Diagnosis and During the Indolent Course of This Condition

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only